Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide

被引：19

作者：

Maurer, Gabriele D. ^{[1
,2
,3
,4
]}

Heller, Sonja ^{[1
,2
,3
,4
]}

Wanka, Christina ^{[1
,2
,3
,4
]}

Rieger, Johannes ^{[1
,2
,3
,4
,5
]}

Steinbach, Joachim P. ^{[1
,2
,3
,4
]}

机构：

[1] Goethe Univ, Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, D-60590 Frankfurt, Germany

[2] Goethe Univ, Univ Hosp Frankfurt, Univ Canc Ctr UCT, D-60590 Frankfurt, Germany

[3] German Canc Res Ctr DKFZ Heidelberg, D-60590 Frankfurt, Germany

[4] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, D-60590 Frankfurt, Germany

[5] Eberhard Karls Univ Tubingen, Univ Hosp Tuebingen, Hertie Inst Clin Brain Res, Interdisciplinary Div Neurooncol, D-72076 Tubingen, Germany

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2019年 / 20卷 / 05期

关键词：

TP53-induced glycolysis and apoptosis regulator; glioma; hypoxia; irradiation; temozolomide; reactive oxygen species; hypoxia-inducible factor; TUMOR-SUPPRESSOR; P53; GLIOBLASTOMA; RADIOSENSITIZATION; MICROENVIRONMENT; IDENTIFICATION; PROGRESSION; PROGNOSIS; PROTECTS; HIF-1;

D O I：

10.3390/ijms20051061

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The TP53-induced glycolysis and apoptosis regulator (TIGAR) has been shown to decrease glycolysis, to activate the pentose phosphate pathway, and to provide protection against oxidative damage. Hypoxic regions are considered characteristic of glioblastoma and linked with resistance to current treatment strategies. Here, we established that LNT-229 glioma cell lines stably expressed shRNA constructs targeting TIGAR, and exposed them to hypoxia, irradiation and temozolomide. The disruption of TIGAR enhanced levels of reactive oxygen species and cell death under hypoxic conditions, as well as the effectiveness of irradiation and temozolomide. In addition, TIGAR was upregulated by HIF-1. As a component of a complex network, TIGAR contributes to the metabolic adjustments that arise from either spontaneous or therapy-induced changes in tumor microenvironment.

引用

页数：14

共 47 条

[31] Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage (vol 176, pg 919, 2019)
Mao, Z.
Han, X.
Chen, D.
Xu, Y.
Xu, L.
Yin, L.
Sun, H.
Qi, Y.
Fang, L.
Liu, K.
Peng, J.
BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (16) : 3354 - 3355
[32] Wnt Signaling Activates TP53-Induced Glycolysis and Apoptosis Regulator and Protects Against Cisplatin-Induced Spiral Ganglion Neuron Damage in the Mouse Cochlea
Liu, Wenwen
Xu, Xiaochen
Fan, Zhaomin
Sun, Gaoying
Han, Yuechen
Zhang, Daogong
Xu, Lei
Wang, Mingming
Wang, Xue
Zhang, Shasha
Tang, Mingliang
Li, Jianfeng
Chai, Renjie
Wang, Haibo
ANTIOXIDANTS & REDOX SIGNALING, 2019, 30 (11) : 1389 - 1410
[33] Melatonin ameliorates hypoglycemic stress-induced brain endothelial tight junction injury by inhibiting protein nitration of TP53-induced glycolysis and apoptosis regulator
Wang, Cheng-kun
Ahmed, Muhammad Masood
Jiang, Quan
Lu, Nan-nan
Tan, Chao
Gao, Yin-ping
Mahmood, Qaisar
Chen, Dan-yang
Fukunaga, Kohji
Li, Mei
Chen, Zhong
Wilcox, Christopher S.
Lu, Ying-mei
Qin, Zheng-hong
Han, Feng
JOURNAL OF PINEAL RESEARCH, 2017, 63 (04)
[34] TP53-induced glycolysis and apoptosis regulator (TIGAR) ameliorates lysosomal damage in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-mediated mouse model of Parkinson's disease
Ge, Jianbin
Lin, Hongyan
Yang, Jie
Li, QiQi
Zhou, Jingsi
Qin, Zhenghong
Wu, Feng
TOXICOLOGY LETTERS, 2021, 339 : 60 - 69
[35] The Downregulation of CRIF1 Exerts Antitumor Effects Partially via TP53-Induced Glycolysis and Apoptosis Regulator Induction in BT549 Breast Cancer Cells
Piao, Shuyu
Kim, Seonhee
Vu, Giang-Huong
Kim, Minsoo
Lee, Eun-Ok
Jeon, Byeong Hwa
Kim, Cuk-Seong
CANCERS, 2024, 16 (23)
[36] SOT302: Dual expression of exogenous glutamine oxaloacetate transaminase (GOT2) and TP53-induced glycolysis and apoptosis regulator (TIGAR) enhance CAR T cell activity in preclinical solid tumor models
Kuiper, Emily
Bhaduri, Samyabrata
Garafola, Daniel
Sharma, Kshitij
Coccia, Jennifer
Whiteman, Kathleen
Jensen-Smith, Amy
CANCER RESEARCH, 2024, 84 (06)
[37] High expression of synthesis of cytochrome c oxidase 2 and TP53-induced glycolysis and apoptosis regulator can predict poor prognosis in human lung adenocarcinoma
Liu, Jiabin
Lu, Funian
Gong, Yan
Zhao, Chen
Pan, Qi
Ballantyne, Stephanie
Zhao, Xianda
Tian, Sufang
Chen, Honglei
HUMAN PATHOLOGY, 2018, 77 : 54 - 62
[38] An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation
Lui, Vivian Wai Yan
Lau, Cecilia Pik Yuk
Cheung, Crystal Sao Fong
Ho, Kakiu
Ng, Margaret Heung Ling
Cheng, Suk Hang
Hong, Bo
Tsao, Sai-Wah
Tsang, Chi Man
Lei, Kenny Ieng Kit
Yamasaki, Yasundo
Mita, Akira
Chan, Anthony T. C.
BIOCHEMICAL PHARMACOLOGY, 2010, 79 (12) : 1772 - 1780
[39] miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in Prostate Cancer Cells
Huang, Shiqiao
Yang, Zhiguo
Ma, Yong
Yang, Yiyong
Wang, Shangren
DNA AND CELL BIOLOGY, 2017, 36 (04) : 303 - 310
[40] The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma
Hutchison, Tetiana
Malu, Aditi
Yapindi, Lacin
Bergeson, Rachel
Peck, Kendra
Romeo, Megan
Harrod, Carolyn
Pope, Jordan
Smitherman, Louisa
Gwinn, Wesleigh
Ratner, Lee
Yates, Courtney
Harrod, Robert
VIROLOGY, 2018, 520 : 39 - 58

← 1 2 3 4 5 →